Regulatory PathRegulatory requirements compared

Active substance

Piroxicam

Open in the medicines table

SFDA Saudi Arabia — SFDA human drug list

Trade nameStrengthForm · routePackPublic priceTypeCompanyStatus
DISPERCAM 20MG-ML AMP.FOR I-M USE20 mg/mlSolution for injection · Intramuscular use3 AmpouleSAR 2.65Generic · PrescriptionMEDICAL UNION PHARMACEUTICALS COValid
DISPERCAM GEL 0.5%0.5 %Gel · Topical1 TubeSAR 2.80Generic · OTCMEDICAL UNION PHARMACEUTICALS COValid
FELDENE 20MG DISPERSABLE TAB20 mgDispersible tablet · Oral use10 BlisterSAR 22.50NCE · PrescriptionSPIMACO ADDWAEIHValid
FELDENE 20MG-ML AMP.20 mg/mlSolution for injection · Intramuscular use5 AmpouleSAR 29.20NCE · PrescriptionSPIMACO ADDWAEIHValid
BREXIN 20MG TABLETS20 mgTablet · Oral use10 BlisterSAR 8.65Generic · PrescriptionCHIESI FARMACEUTICISWithdrawn by MAH · Not Marketed
FELDENE 10MG CAPS10 mgCapsule · Oral use20 BlisterSAR 26.00Generic · PrescriptionSPIMACO ADDWAEIHWithdrawn by MAH · Not Marketed
FELDENE 10MG DISPERSABLE TAB10 mgDispersible tablet · Oral use20 BlisterSAR 22.50NCE · PrescriptionSPIMACO ADDWAEIHWithdrawn by MAH · Not Marketed
FELDENE 20MG CAPS20 mgCapsule · Oral use10 BlisterSAR 22.65Generic · PrescriptionSPIMACO ADDWAEIHWithdrawn by MAH · Not Marketed
FELDENE 20MG SUPPOSITORY20 mgSuppository · Rectal use20 BlisterSAR 22.55NCE · PrescriptionPFIZERWithdrawn by MAH · Not Marketed
FELDENE GEL 0.5%0.5 %Gel · Topical1 TubeSAR 13.35NCE · OTCSPIMACO ADDWAEIHWithdrawn by MAH · Not Marketed
NOVO-PIROCAM 10MG CAPS10 mgCapsule · Oral use20 BlisterSAR 20.75NCE · PrescriptionNOVOPHARMWithdrawn by MAH · Not Marketed
ORTHOCAM 0.5% GEL0.5 %Gel · Topical1 TubeSAR 10.65Generic · OTCTabuk Pharmaceutical Manufacturing CompanyWithdrawn by MAH · Not Marketed
ORTHOCAM 10 CAPS10 mgCapsule · Oral use20 BlisterSAR 21.60Generic · PrescriptionTabuk Pharmaceutical Manufacturing CompanyWithdrawn by MAH · Not Marketed
ORTHOCAM 20 CAPS20 mgCapsule · Oral use10 BlisterSAR 18.85Generic · PrescriptionTabuk Pharmaceutical Manufacturing CompanyWithdrawn by MAH · Not Marketed
ORTHOCAM DT 10MG10 mgDispersible tablet · Oral use20 BlisterSAR 18.95Generic · PrescriptionTabuk Pharmaceutical Manufacturing CompanyWithdrawn by MAH · Not Marketed
ORTHOCAM DT 20MG20 mgDispersible tablet · Oral use10 BlisterSAR 18.95Generic · PrescriptionTabuk Pharmaceutical Manufacturing CompanyWithdrawn by MAH · Not Marketed
SHIFA PIROXICAM 20 MG-ML I.M AMP20 mg/mlInjection · Intramuscular use5 AmpouleSAR 3.85NCE · PrescriptionSHIFA PHARMACEUTICAL INDUSTRIESInvalid · Not Marketed
Indications — CHI Daman Drug Formulary

ACUTE PANCREATITIS-PAIN MANAGEMENT; ENDOMETRIOSIS; LOW BACK PAIN; PAIN MANAGEMENT IN CANCER PATIENTS; POSTOPERATIVE PAIN; RENAL AND URETERIC STONES; RHEUMATOID ARITHRITIS

US FDA United States — FDA approvals (Drugs@FDA)

ProductStrengthForm · routeApplicantStatusFirst approved
FELDENE10MG; 20MGcapsule · oralPFIZERPrescription6 Apr 1982
PIROXICAM10MG; 20MGcapsule · oralTEVAPrescription11 Dec 1992
PIROXICAM20MG; 10MGcapsule · oralSOLIS PHARMSPrescription15 Jun 1993
PIROXICAM10MG; 20MGcapsule · oralMICRO LABSPrescription29 Dec 2017
PIROXICAM10MG; 20MGcapsule · oralSTRIDES PHARMAPrescription26 Jan 2018
PIROXICAM10MG; 20MGcapsule · oralZYDUS LIFESCIENCESPrescription17 Jul 2018
PIROXICAM10MG; 20MGcapsule · oralSCSDiscontinued29 May 1992
PIROXICAM10MG; 20MGcapsule · oralPHARMOBEDIENTDiscontinued31 Jul 1992
PIROXICAM10MG; 20MGcapsule · oralTEVA PHARMSDiscontinued28 Aug 1992
PIROXICAM10MG; 20MGcapsule · oralMYLANDiscontinued22 Sep 1992
PIROXICAM20MG; 10MGcapsule · oralSUN PHARM INDUSTRIESDiscontinued12 Mar 1993
PIROXICAM10MGcapsule · oralTEVADiscontinued28 Jan 1994
PIROXICAM20MGcapsule · oralTEVADiscontinued28 Jan 1994
PIROXICAM10MG; 20MGcapsule · oralWATSON LABSDiscontinued29 Sep 1995
PIROXICAM10MG; 20MGcapsule · oralWATSON LABSDiscontinued16 May 1996
PIROXICAM10MG; 20MGcapsule · oralIVAX SUB TEVA PHARMSDiscontinued3 Jun 1996
PIROXICAM10MG; 20MGcapsule · oralEGISDiscontinued8 Jul 1997
PIROXICAM10MG; 20MGcapsule · oralFLAMINGO PHARMSDiscontinued9 Sep 2016
PIROXICAM10MG; 20MGcapsule · oralUNICHEMDiscontinued13 Apr 2017
PIROXICAM10MG; 20MGcapsule · oralSTRIDES PHARMADiscontinued20 Jun 2017
PIROXICAM10MG; 20MGcapsule · oralHIKMADiscontinued11 Aug 2017
PIROXICAM10MG; 20MGcapsule · oralBRECKENRIDGEDiscontinued21 Feb 2018
PIROXICAM10MG; 20MGcapsule · oralCYCLEDiscontinued

Canada Canada — marketed products (Health Canada)

BrandDINStrengthForm · routeCompany
APO PIROXICAM CAP 10MG0064288610 MGCAPSULE · ORALAPOTEX INC
APO PIROXICAM CAP 20MG0064289420 MGCAPSULE · ORALAPOTEX INC
TEVA-PIROXICAM0069569620 MGCAPSULE · ORALTEVA CANADA LIMITED
TEVA-PIROXICAM0069571810 MGCAPSULE · ORALTEVA CANADA LIMITED

Prices — United States and England

SourceProduct as listedPriceUnit / packDate
US NADACPIROXICAM 10 MG CAPSULE$0.15768per EA23 Sep 2026
US NADACPIROXICAM 20 MG CAPSULE$0.21465per EA23 Sep 2026
NHS Drug TariffPiroxicam 0.5% gel£1.4960 gram1 Oct 2026
NHS Drug TariffPiroxicam 0.5% gel£2.78112 gram1 Oct 2026
NHS Drug TariffPiroxicam 10mg capsules£16.0056 capsule1 Oct 2026
NHS Drug TariffPiroxicam 20mg capsules£24.0028 capsule1 Oct 2026
NHS Drug TariffPiroxicam 20mg orodispersible tablets sugar free£10.5330 tablet1 Oct 2026

NADAC: average price US retail pharmacies pay to buy the medicine. NHS Drug Tariff Part VIIIA: basic price reimbursed to pharmacies in England and Wales.

Safety signals and safety-related labeling changes

All safety entries for piroxicam →

Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.